THY1 and ovarian cancer: Interestingly these authors have also indicated that Thy-1/CD90-β3 integrin interaction inhibits ovarian cancer formation (Chen et al., 2016) and in this case, CD133 decreases its expression in cancer stem cells, while the phosphorylation of AMPK increases.